Jim Simons Biofrontera Inc. Transaction History

Renaissance Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.4 - $0.65 $5,880 - $9,555	14,700 Added 41.14%	50,434 $26,000
Q1 2023 May 12, 2023	BUY	$0.56 - $1.02 $8,848 - $16,116	15,800 Added 79.26%	35,734 $22,000
Q4 2022 Feb 13, 2023	BUY	$0.77 - $1.05 $4,620 - $6,300	6,000 Added 43.06%	19,934 $18,000
Q3 2022 Nov 14, 2022	BUY	$0.82 - $1.26 $11,425 - $17,556	13,934 New	13,934 $15,000

Ticker BFRI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 23,551,000
Market Cap $19.3M
Description
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for phot...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.